SunHo is a biopharmaceutical company committed to the discovery, development and commercialization of first-in-class/best-in-class biologics that regulate immune microenvironment by directly modulating both the innate and adaptive immune systems. Leveraging our deep understanding of immunology, we have developed various types of immunotherapies including immunocytokines to treat cancers and autoimmune diseases. Since our inception in 2018, we have built fully-integrated, end-to-end, in-house R&D capabilities encompassing all the key biological drug development functionalities, including discovery, antibody and protein engineering, process development, preclinical pharmacology studies, clinical development, and good manufacturing practice (“GMP”)-compliant manufacturing. BD contact: chenzi@sunho.com
